Compare CAE & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAE | ALGN |
|---|---|---|
| Founded | 1947 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.3B |
| IPO Year | N/A | N/A |
| Metric | CAE | ALGN |
|---|---|---|
| Price | $34.23 | $172.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $33.75 | ★ $179.09 |
| AVG Volume (30 Days) | 477.9K | ★ 929.4K |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.97 | ★ 5.16 |
| Revenue | $3,470,482,234.00 | ★ $3,982,622,000.00 |
| Revenue This Year | $6.40 | $2.58 |
| Revenue Next Year | $5.37 | $3.66 |
| P/E Ratio | $35.03 | ★ $33.22 |
| Revenue Growth | ★ 9.12 | 0.56 |
| 52 Week Low | $20.36 | $122.00 |
| 52 Week High | $34.24 | $237.23 |
| Indicator | CAE | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 76.45 | 69.29 |
| Support Level | $32.36 | $167.40 |
| Resistance Level | $33.48 | $174.01 |
| Average True Range (ATR) | 0.66 | 4.19 |
| MACD | 0.10 | 0.41 |
| Stochastic Oscillator | 98.96 | 90.48 |
CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.